Exploring New Treatment Options for Severe Sickle Cell Disorder : The Redress Study
Exploring New Treatment Options for Severe Sickle Cell Disorder: The REDRESS study Living with... Read More
Have you experienced stroke? Share your experiences.
The University of the West of England (UWE) in Bristol, and Kingston University in London... Read More
Participants needed for research
We are supporting the University of Nottingham in its call for participants in a study... Read More
All you need to know about Gene Therapy and New Therapies for Sickle Cell
Join us for our free Patient Education Day on Saturday 1st July where we will... Read More
SCS response to European Medicines Agency (EMA) and Committee for Medicinal Products for Human Use (CHMP) updates on Crizanlizumab
This statement is an update to our previous statement on Crizanlizumab made on the 31/1/23.... Read More
CSL Vifor VIT-2763 Clinical Trial in SCD
Vision Serentiy are looking for Volunteers to join their Sickle Cell Study Research Programme of... Read More
SCS response to European Medicines Agency (EMA) and Novartis updates on Crizlanlizumab
As many of you will know Crizanlizumab (Adakveo) was recommended as a new disease modifying... Read More
PERICLES (Prenatal Therapy for Sickle Cell Disease)
The Sickle Cell Society is working with King’s College on a project looking at people’s... Read More
CSL889 Clinical Trial
About CSL889 CSL889 is a new potential treatment under development for the symptoms of SCD.... Read More
Transfusion Antenatally in Pregnant Women with SCD (TAPS2)
Transfusion Antenatally in Pregnant Women with SCD (TAPS2) Pregnant women with Sickle Cell Disease (SCD)... Read More
IMR-687 Clinical Trial
Imara Inc., is dedicated to developing novel therapeutics for patients with sickle cell disease. Despite... Read More
